Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00217074 · ClinicalTrials.gov registry record · Phase 3

Acupuncture and Hot Flashes

A Phase 3 study, sponsored by Mayo Clinic.

Terminated
Registry status
Phase 3
Development phase
103
Enrollment target

NCT00217074: Clinical Trial Phase 3 study, sponsored by Mayo Clinic.

NCT00217074 is a Phase 3 study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 103 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00217074, a Phase 3 study, was terminated before completion, sponsored by Mayo Clinic.

TERMINATED
Registry status
Phase 3
Development phase
103 participants
Enrollment target

Study Summary

Methods: 103 participants, after being randomized to medical versus sham acupuncture received bi-weekly treatments for 5 weeks, after a baseline assessment week. They were then followed for an additional 7 weeks. Participants completed daily hot flash questionnaires, which formed the basis for analysis.

Interventions

  • OTHER acupuncture

Trial Details

FieldValue
Enrollment Target 103 participants
Start Date 2004-01
Est. Completion 2005-10
Phase Phase 3
Mayo Clinic

2,844 total trials

Why NCT00217074 stopped before completion

NCT00217074 is an interventional study that assigns participants to a tested intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (87% lower).

The record links to 0 conditions, and to 1 intervention - of which acupuncture is the first listed.

NCT00217074 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00217074 about?

NCT00217074 is a clinical study titled "Acupuncture and Hot Flashes". Methods: 103 participants, after being randomized to medical versus sham acupuncture received bi-weekly treatments for 5 weeks, after a baseline assessment week. They were then followed for an additional 7 weeks. Participants completed daily hot flash questionnaires, which formed the basis for analy...

What is the current status of trial NCT00217074?

This trial is currently terminated. It is a Phase 3 study. The enrollment target is 103 participants. The study started on 2004-01. Estimated completion is 2005-10.

What interventions are being tested in trial NCT00217074?

The interventions under investigation include: acupuncture (OTHER).

Who is sponsoring clinical trial NCT00217074?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00217074's enrollment target sits among peer trials

103 1674th of 2000 higher than 325 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04690348 · 103 participants · Phase 2

    Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study

  • NCT05282277 · 103 participants · Phase 4

    Examining the Effects of Estradiol on Neural and Molecular Response to Reward

  • NCT05566769 · 103 participants · NA

    Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD

  • NCT05834478 · 103 participants · Phase 3

    Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00217074, the US trial registry maintained by the National Library of Medicine. NCT00217074 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.